Reaction
Complications Of Transplanted Lung reporting signals
As of the last recalculation, Complications Of Transplanted Lung appears in 301 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 378.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 53 | 378.0 | 379.7 |
| Tacrolimus Ointment 0.1% | 131 | 128.0 | 128.2 |
| Tacrolimus Extended-Release Capsules | 131 | 127.7 | 127.8 |
| Tacrolimus | 147 | 125.9 | 126.0 |
| Mycophenolate Mofetil | 120 | 100.9 | 101.0 |
| Mycophenolate Mofetil Hydrochloride | 120 | 100.8 | 100.8 |
| Ganciclovir Sodium | 14 | 95.9 | 96.0 |
| Valganciclovir Hydrochloride Powder, | 15 | 89.4 | 89.6 |
| Ganciclovir | 12 | 84.4 | 84.5 |
| Valganciclovir | 20 | 78.5 | 78.6 |
| Valganciclovir Hydrochloride | 20 | 78.5 | 78.6 |
| Sofosbuvir | 19 | 71.0 | 71.1 |
| Sirolimus | 13 | 69.7 | 69.8 |
| Everolimus Tablets | 14 | 60.5 | 60.6 |
| Mycophenilic Acid | 17 | 60.1 | 60.1 |